When was Symbiotec founded?

Symbiotec was founded in 2002 and raised its 1st funding round 5 years after it was founded.

Where is Symbiotec located?

Symbiotec is headquartered in Indore, India. It is registered at 385/2, Pigdamber, Rau, Pigdamber, Indore, Mhow, Madhya Pradesh, India, 453331.

Which legal entities is Symbiotec associated with?

Symbiotec is associated with SYMBIOTEC PHARMALAB LIMITED and 4 others.

How many employees does Symbiotec have?

As of May 31, 2025, the latest employee count at Symbiotec is 1822.

Is Symbiotec a funded company?

Symbiotec is a funded company, having raised a total of $61.1M across 4 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Aug 06, 2007.

How much is Symbiotec worth?

The last known valuation of Symbiotec was $***** as of Dec 18, 2018.

When was the latest funding round of Symbiotec?

Symbiotec's latest funding was a $***** Series C round on Oct 13, 2013, with participation from 2 investors.

What is the annual revenue of Symbiotec?

Annual revenue of Symbiotec is between ₹500 Cr and ₹1,000 Cr as on Mar 31, 2025

Where does Symbiotec rank among its competitors?

Symbiotec ranks 2nd amongst 959 active competitors, of which 38 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was Embio, which secured $50M in May, 2026.

Who are the top competitors of Symbiotec?

Symbiotec's top competitors include Laurus Labs, NGL Fine Chem and Neuland. Among them, Embio secured the most recent funding round in May, 2026.

Symbiotec - 2026 Company Profile, Team, Funding, Competitors & Financials

Symbiotec is an acquired company based in Indore (India), founded in 2002 by Anil Satwani. It operates as a Manufacturer of non sterile steroid hormone based APIs and intermediates. Symbiotec has raised $61.1M in funding from investors like Actis, Franklin Templeton Investments and Soyumm Marketing, with last known valuation of $*****. The company has 959 active competitors, including 38 funded and 137 that have exited. Its top competitors include companies like Laurus Labs, NGL Fine Chem and Neuland.

Company Details

Manufacturer of non sterile steroid hormone based APIs and intermediates. Its therapeutic areas includes gastrointestinal ailments, cardiovascular disease, pain management, paediatrics, anti-infective, and dermatology sectors. It also provides regulatory-compliant solutions. The company focuses on research and quality control laboratories.

Website: symbiotec.in
Social
Email ID: *****@symbiotec.in
Phone Number: +91 **********
Registered Address: 385/2, Pigdamber, Rau, Pigdamber, Indore, Mhow, Madhya Pradesh, India, 453331

Key Metrics

Founded Year

2002

Location

Indore, India

Stage

Acquired

Total Funding

$61.1M in 4 rounds

Latest Funding Round

Series C, Oct 13, 2013, $*****

Last Known Valuation

$***** as on Dec 18, 2018

Investors

Actis & 22 more

Ranked

2^nd among 959 active competitors

Annual Revenue

₹500 - ₹1,000 Cr as on Mar 31, 2025

Employee Count

1,822 as on May 31, 2025

Similar Companies

Laurus Labs & 1223 more

Exit Details

Acquired by Rosewood Private Intvestments (Dec 18, 2018)

View Symbiotec's full profile

Symbiotec is associated with 5 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count
Tdv Commercials Llp CIN: ACA-1775 , India, Active	Mar 11, 2023	0 - ₹10 Cr (As on Mar 31, 2025)	-
Symbiotec Lifesciences Private Limited CIN: U33100MP2020PTC052495 , India, Active	Aug 25, 2020	-	124 (As on May 31, 2025)
KNOVEA PHARMACEUTICAL PRIVATE LIMITED CIN: U24110MP2020PTC050978 , India, Active	Feb 17, 2020	0 - ₹10 Cr (As on Mar 31, 2025)	177 (As on May 31, 2025)
SPL LIFESCIENCE INDIA PRIVATE LIMITED CIN: U24100MP2015PTC034447 , India, Strike off	Jul 10, 2015	0 - ₹10 Cr (As on Mar 31, 2017)	177 (As on May 31, 2025)
SYMBIOTEC PHARMALAB LIMITED CIN: U24232MP2002PLC015293 , India, Active	Sep 20, 2002	₹500 - ₹1,000 Cr (As on Mar 31, 2025)	1484 (As on May 01, 2026)

Symbiotec got acquired by Rosewood Private Intvestments and India Excellence Fund III on Dec 18, 2018 at an acquisition amount of $*****.

Click here to take a look at Symbiotec's acquisition in detail

Symbiotec has raised a total funding of $61.1M over 4 rounds. Its first funding round was on Aug 06, 2007. Its latest funding round was a Series C round on Oct 13, 2013 for $*****. 2 investors participated in its latest round. Symbiotec has 11 institutional investors and 12 angel investors.

Here is the list of recent funding rounds of Symbiotec:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 13, 2013	1815208	Series C	9125090	4889889	5766190	4156148
Mar 29, 2013	4811229	Angel	9603657	3933482	7508617	5215863
Sep 15, 2011	5596299	Series A	1471799	4135175	Franklin Templeton Investments	9749928

Access funding benchmarks and valuations. Sign up today!

View details of Symbiotec's funding rounds and investors

The founders of Symbiotec is Anil Satwani.

Here are the details of Symbiotec's key team members:

Anil Satwani: Founder & Managing Director of Symbiotec and founder of 1 other company. They serve on the board of 1 company.
Contact Info: 1 email address and 1 phone number

Symbiotec's Board of Directors

Symbiotec's board has 4 active members. Anil Satwani, Buggana Hariharnath, Rohit Brijmohan Mantri and Shankar Gopalakrishnan are part of team.

Here is the list of Symbiotec's board of directors:

Name	Type	Representing	Status	Duration
Anil Satwani	Team	-	Current	21y 3m
Rohit Brijmohan Mantri	Investor	-	Current	6y 11m
sqmnuxi	Investor	-	Past	9y 9m
d{pltqg	Investor	-	Past	6y 4m

View details of Symbiotec's Founder profiles and Board Members

Symbiotec's employee count trend

Symbiotec has 1,822 employees as of May 25. The total employee count is 10.0% more than what it was in May 24. Here is Symbiotec's employee count trend over the years:

Uncover Symbiotec's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Symbiotec include Laurus Labs, NGL Fine Chem and Neuland. Here is the list of Top 10 competitors of Symbiotec, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Laurus Labs 2005, Hyderabad (India), Public	Pharmaceutical and biotechnology company	$230M	F-Prime Capital, IKP Knowledge Park & 3 others	78/100
2nd	Symbiotec 2002, Indore (India), Acquired	Manufacturer of non sterile steroid hormone based APIs and intermediates	$61.1M	InvAscent, Motilal Oswal Private Equity & 21 others	64/100
3rd	NGL Fine Chem 1981, Mumbai (India), Public	CDMO specializing in multi stage organic synthesis of generic APIs and fine chemicals	-	-	59/100
4th	Neuland 1984, Hyderabad (India), Public	Manufacturer of active pharmaceutical ingredients (APIs) and peptides	-	India Capital Growth, InvAscent & 1 others	58/100
5th	Embio 1986, Mumbai (India), Late Stage	Contract research and manufacturing company engaged in APIs and chiral intermediates	$50.3M	UTI, GURU NARAYAN FINCAP & 26 others	58/100
6th	Snapdragon Chemistry 2014, Cambridge (United States), Acquired	CDMO providing API development, manufacturing, and analytical services	-	Asymchem, C2I Accelerator & 1 others	55/100
7th	SeQuent 2002, Bengaluru (India), Acquired	APIs Manufacturer	-	Nepean Capital, Thecarlylegroup.fr & 2 others	54/100
8th	ST PHARM 2008, Siheung si (South Korea), Public	CDMO providing oligonucleotide, mRNA, and small molecule services	-	E&Investment, Synergy IB investment & 1 others	54/100
9th	Hikal 1988, Mumbai (India), Public	Traditional company offering contract research, custom synthesis & custom manufacturing of APIs and intermediates	-	IFC	53/100
10th	Enaltec Labs 2006, Mumbai (India), Acquired	Provider of complex small-volume technology-driven pharmaceutical products	$8.56M	InvAscent, Medtech Global & 7 others	52/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Symbiotec's competitors? Click here to see the top ones

Founders own 4.89%, Funds (largest shareholder) own 42.92%, Parent Entities own 17.32% and Enterprises own 11.55%. The net worth of Symbiotec's founders is INR 20.5Cr as of Oct 21, 2013.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	4.89%	20.5Cr	5027	6018	6789	2220
Anil Satwani	1487	1711	6680	7488	2261	5664
Fund	42.92%	179Cr	3635718	2360165	6630072	3151176
Actis	2994831	9282184	1493879	3885231	6984741	7418609
Franklin Templeton Investments	4003642	6807608	1278592	1038531	8421464	9688644
Parent Entity	17.32%	72.4Cr	9076667	3165039	8709118	4567437
Enterprise	11.55%	48.3Cr	9149134	3381940	1371469	2060247
Angel	13.95%	58.3Cr	4186324	4505964	9958728	2770700
Rakesh Radheyshyam Jhunjhunwala	760089	896466	140902	663961	242169	446304
Other People	9.37%	39.2Cr	7468619	9333345	4631485	5682516
Total	100.00%	418Cr	4596206	3166285	7981346	4043845